Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...
13h
GlobalData on MSNJ&J sues Samsung Bioepis over ‘surreptitious’ breach of Stelara biosimilar contractSamsung Bioepis has allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...
Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...
Johnson & Johnson filed a lawsuit against Samsung Bioepis for allegedly breaching their agreement over the launch of ...
Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...
Walgreens said it had entered into a settlement agreement with telemedicine provider Everly Health Solutions as part of which ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
Johnson & Johnson is suing Samsung Bioepis for allegedly breaching the terms of a contract regarding the launch of the Korean ...
4h
Chambersburg Public Opinion on MSNCentral Atlantic region gas prices slightly declined from last week: See how much hereHere's a look at how weekly regional gas prices changed in Central Atlantic region last week compared with the week prior.
Canada's Marketing Hall of Legends, one of Canada's most respected and renowned industry awards, is proud to announce this ...
Applications are now open for grants from the Minnesota Department of Agriculture (MDA) to increase the competitiveness of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results